An Overview of the Safety, Efficiency, and Signal Pathways of Stem Cell Therapy for Systemic Lupus Erythematosus
Systemic lupus erythematosus (SLE) is an autoimmune disease that affects multiple organs and tissues. Mesenchymal stem cells (MSCs) are considered a good source for autoimmune disease and hematological disease therapy. This review will summarize the efficacy, safety, and mechanisms of MSC therapy fo...
Main Authors: | Qian Yang, Yiping Liu, Guangyong Chen, Wancong Zhang, Shijie Tang, Tianbiao Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2021/2168595 |
Similar Items
-
Clinical Efficacy and Safety of Mesenchymal Stem Cells for Systemic Lupus Erythematosus
by: Tianbiao Zhou, et al.
Published: (2020-01-01) -
Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus
by: I-Tsu Chyuan, et al.
Published: (2019-08-01) -
Mesenchymal Stem Cell Therapy: Hope for Patients With Systemic Lupus Erythematosus
by: Aifen Li, et al.
Published: (2021-09-01) -
Efficacy and Safety of Vaccinations in Systemic Lupus Erythematosus
by: Philip Hei Li, et al.
Published: (2020-07-01) -
Dysregulated intracellular signalling pathways in T lymphocytes from patients with systemic lupus erythematosus
by: Jury, Elizabeth Carole
Published: (2004)